EICHOR
● Active Not Recruiting
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
Condition: Endometrial Cancer · Sponsor: Gilead Sciences
About this study
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemotherapy and immunotherapy, versus the treatment of physician's choice (TPC). The primary objectives of this study are to evaluate the effect of SG compared to TPC on progression-free survival (PFS) as assessed by blinded independent central review (BICR) and overall survival (OS).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (189)
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| City of Hope | Duarte, California, United States | — |
| UC San Diego Medical Center | La Jolla, California, United States | — |
| Cedars-Sinai Cancer at Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| Stanford Women's Cancer Center | Palo Alto, California, United States | — |
| Kaiser Permanente Medical Center | Vallejo, California, United States | — |
| University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) | Aurora, Colorado, United States | — |
| Hartford HealthCare Cancer Institute at Hartford Hospital | Hartford, Connecticut, United States | — |
| Yale University School of Medicine | New Haven, Connecticut, United States | — |
| Florida Cancer Specialists | Fort Myers, Florida, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Baptist MD Anderson Cancer Center | Jacksonville, Florida, United States | — |
+ 177 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.